Blood-based extracellular matrix biomarkers as predictors of survival in patients with metastatic pancreatic ductal adenocarcinoma receiving pegvorhyaluronidase alfa
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blood-based extracellular matrix biomarkers as predictors of survival in patients with metastatic pancreatic ductal adenocarcinoma receiving pegvorhyaluronidase alfa
Authors
Keywords
-
Journal
Journal of Translational Medicine
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-21
DOI
10.1186/s12967-021-02701-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Vastatin (the NC1 domain of human type VIII collagen a1 chain) is linked to stromal reactivity and elevated in serum from patients with colorectal cancer
- (2019) Nicholas Willumsen et al. CANCER BIOLOGY & THERAPY
- Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer
- (2019) Inna M. Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Collagen fragments quantified in serum as measures of desmoplasia associate with survival outcome in patients with advanced pancreatic cancer
- (2019) Nicholas Willumsen et al. Scientific Reports
- Parallel Accumulation of Tumor Hyaluronan, Collagen and Other Drivers of Tumor Progression
- (2018) Xiaoming Li et al. CLINICAL CANCER RESEARCH
- HALO-109–301: a Phase III trial of PEGPH20 (with gemcitabine and nab-paclitaxel) in hyaluronic acid-high stage IV pancreatic cancer
- (2018) Gary J Doherty et al. Future Oncology
- Biomolecular analysis of matrix proteoglycans as biomarkers in non small cell lung cancer
- (2018) Maristela P. Rangel et al. GLYCOCONJUGATE JOURNAL
- High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts
- (2018) Allan Lipton et al. INTERNATIONAL JOURNAL OF CANCER
- HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma
- (2018) Sunil R. Hingorani et al. JOURNAL OF CLINICAL ONCOLOGY
- Protein Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma: Progress and Challenges
- (2018) Alex Root et al. Cancers
- Proteoglycans Are Attractive Biomarkers and Therapeutic Targets in Hepatocellular Carcinoma
- (2018) Yasuo Tanaka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint blockade (anti-CTLA-4) in metastatic melanoma patients
- (2018) Christina Jensen et al. Journal for ImmunoTherapy of Cancer
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Current and future biomarkers for pancreatic adenocarcinoma
- (2017) Sven H Loosen et al. TUMOR BIOLOGY
- Interstitial Pressure in Pancreatic Ductal Adenocarcinoma Is Dominated by a Gel-Fluid Phase
- (2016) Christopher C. DuFort et al. BIOPHYSICAL JOURNAL
- Type VIII collagen is elevated in diseases associated with angiogenesis and vascular remodeling
- (2016) Niels Ulrik Brandt Hansen et al. CLINICAL BIOCHEMISTRY
- Excessive collagen turnover products are released during colorectal cancer progression and elevated in serum from metastatic colorectal cancer patients
- (2016) S. N. Kehlet et al. Scientific Reports
- Collagen degradation products measured in serum can separate ovarian and breast cancer patients from healthy controls: A preliminary study
- (2015) C.L. Bager et al. Cancer Biomarkers
- Proteoglycans as potential microenvironmental biomarkers for colon cancer
- (2015) Anastasia V. Suhovskih et al. CELL AND TISSUE RESEARCH
- Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer
- (2015) C. J. Whatcott et al. CLINICAL CANCER RESEARCH
- Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma
- (2015) Michela Capello et al. JNCI-Journal of the National Cancer Institute
- Hyaluronan Controls the Deposition of Fibronectin and Collagen and Modulates TGF-β1 Induction of Lung Myofibroblasts
- (2015) Stephen P. Evanko et al. MATRIX BIOLOGY
- Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma
- (2015) Michela Capello et al. JNCI-Journal of the National Cancer Institute
- Collagen Type III and VI Turnover in Response to Long-Term Immobilization
- (2015) Shu Sun et al. PLoS One
- Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
- (2014) T Golan et al. BRITISH JOURNAL OF CANCER
- Tumor-Associated Hyaluronan Limits Efficacy of Monoclonal Antibody Therapy
- (2014) N. C. Singha et al. MOLECULAR CANCER THERAPEUTICS
- Therapeutic options for the management of pancreatic cancer
- (2014) Maria L Rossi WORLD JOURNAL OF GASTROENTEROLOGY
- Hyaluronan enhances wound repair and increases collagen III in aged dermal wounds
- (2014) Mamatha Damodarasamy et al. WOUND REPAIR AND REGENERATION
- Serum biomarkers reflecting specific tumor tissue remodeling processes are valuable diagnostic tools for lung cancer
- (2014) Nicholas Willumsen et al. Cancer Medicine
- Desmoplasia and Chemoresistance in Pancreatic Cancer
- (2014) Marvin Schober et al. Cancers
- Extracellular matrix specific protein fingerprints measured in serum can separate pancreatic cancer patients from healthy controls
- (2013) Nicholas Willumsen et al. BMC CANCER
- Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial
- (2013) William Greenhalf et al. JNCI-Journal of the National Cancer Institute
- Extracellular Matrix Remodeling: The Common Denominator in Connective Tissue DiseasesPossibilities for Evaluation and Current Understanding of the Matrix as More Than a Passive Architecture, but a Key Player in Tissue Failure
- (2012) Morten A. Karsdal et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
- (2012) Paolo P. Provenzano et al. CANCER CELL
- The Pancreas Cancer Microenvironment
- (2012) C. Feig et al. CLINICAL CANCER RESEARCH
- Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
- (2012) Michael A Jacobetz et al. GUT
- New biomarkers and targets in pancreatic cancer and their application to treatment
- (2012) Eithne Costello et al. Nature Reviews Gastroenterology & Hepatology
- A novel assay for extracellular matrix remodeling associated with liver fibrosis: An enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen
- (2010) N. Barascuk et al. CLINICAL BIOCHEMISTRY
- Enzymatic Depletion of Tumor Hyaluronan Induces Antitumor Responses in Preclinical Animal Models
- (2010) C. B. Thompson et al. MOLECULAR CANCER THERAPEUTICS
- Human Equilibrative Nucleoside Transporter 1 and Human Concentrative Nucleoside Transporter 3 Predict Survival after Adjuvant Gemcitabine Therapy in Resected Pancreatic Adenocarcinoma
- (2009) R. Marechal et al. CLINICAL CANCER RESEARCH
- Youden Index and Optimal Cut-Point Estimated from Observations Affected by a Lower Limit of Detection
- (2008) Marcus D. Ruopp et al. BIOMETRICAL JOURNAL
- Impact of the hyaluronan-rich tumor microenvironment on cancer initiation and progression
- (2008) Naoki Itano et al. CANCER SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started